Citius Pharmaceuticals, Inc. earnings per share and revenue

CTXR earnings per share for the last quarter are -1.50 USD whereas the estimation was -1.53 USD which accounts for 1.75% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are -1.36 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of CTXR earnings per share and revenue dynamics.